⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 1, 1999Nephrology Dialysis Transplantation

Pseudomembranous necrotizing bronchial aspergillosis in a renal transplant recipient

Abdullah Sayıner

View at Publisher

Ask AI

Bookmark

Share

Abstract

A Sayiner, S Kürşat, H Töz, S Duman, B Onal, E Tümbay; Pseudomembranous necrotizing bronchial aspergillosis in a renal transplant recipient., Nephrology Dialysi

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Abdullah Sayıner (1999) studied this question.

synapsesocial.com/papers/6ab87a8053a0eb38d0b18779 https://doi.org/10.1093/ndt/14.7.1784

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Per-protocol repeat kidney biopsy in lupus nephritis: one more branch of the treeNephrology Dialysis Transplantation · Wed,
2Trends in nephrology: tolerance induction through hematopoietic chimerism in kidney transplantationNephrology Dialysis Transplantation · Wed,
3The Veterans Affairs Pentoxifylline in Diabetic Kidney Disease (VA PTXRx) Study: Baseline CharacteristicsNephrology Dialysis Transplantation · Wed,
4C5 Inhibition for Anti-Cancer Therapy-Induced Renal Thrombotic MicroangiopathyNephrology Dialysis Transplantation · Wed,
5Recombinant shingles vaccination and the risk of cardiovascular events: association or causation?Nephrology Dialysis Transplantation · Mon,

More from Nephrology Dialysis Transplantation

From Stone Removal to Disease Management: Do the 2026 EAU Guidelines Call for a New Urology–Nephrology Partnership?Mon,
High sensitivity C-reactive protein and the risk of cardio-kidney outcomes in adults with moderate to severe chronic kidney disease: a nationwide studyFri,
Long forms of cardiac troponin T are independent of kidney function and improve the diagnosis of myocardial infarctionFri,
Aldosterone and Residual Cardiorenal Risk: Pathophysiology and Emerging Therapeutic StrategiesFri,
Anti-CD38 monoclonal antibodies in kidney disease: mechanistic rationale and emerging clinical evidenceThu,